Association between adenomatosis polyposis coli functional status and microsomal prostaglandin E synthase‐1 expression in colorectal cancer
Authors:
- 26 November 2008
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 48 (5) , 401-407
Abstract
Bioactive metabolites downstream of cyclooxygenase-2 (COX-2) generated prostaglandin H2 (PGH2), in particular prostaglandin E2 (PGE2), are thought to play critical roles during the development of colorectal tumors. Previous reports reveal that defects of the tumor suppressor adenomatosis polyposis coli (APC) contribute to COX-2 upregulation in colon tumor cells. We investigated whether a similar relation was present between APC functional status and the expression of microsomal prostaglandin E synthase-1 (mPGES-1), which acts downstream of COX-2 and catalyses the terminal conversion of PGH2 into PGE2. Surprisingly, mPGES-1 mRNA and protein levels were upregulated upon induction of a wild type-APC carrying vector in HT29 colon cancer cells, and downregulated following siRNA silencing of APC in HCT-116 cells. mPGES-1 was overall enhanced in human colorectal tumor specimens versus corresponding non-tumor mucosa and, in accordance with data on HT29 and HCT116 cells, higher levels of mPGES-1 were observed among tumors carrying wild type versus mutant APC. RNAi silencing of β-catenin and luciferase assays regarding the mPGES-1 promoter region did not reveal a role for APC or β-catenin/Tcf in controlling mPGES-1 gene transcription. However, RNA degradation assays in HT29 cells revealed a suppressed degradation of mPGES-1 in the presence of wild type APC, implying that mPGES-1 mRNA is stabilized in the APC wild type state. Collectively, we demonstrate a novel association between APC functional status and mPGES-1 expression in colorectal tumor cells, being most likely related to reduced mPGES-1 mRNA degradation rate in the APC wild type state.Keywords
This publication has 19 references indexed in Scilit:
- Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APCMin/+ miceBiochemical and Biophysical Research Communications, 2008
- Genetic Deletion of mPGES-1 Suppresses Intestinal TumorigenesisCancer Research, 2008
- Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- Prostaglandin E Synthase: A Novel Drug Target for Inflammation and CancerCurrent Pharmaceutical Design, 2006
- Potential Role of Microsomal Prostaglandin E Synthase-1 in TumorigenesisJournal of Biological Chemistry, 2003
- Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational levelCarcinogenesis, 1999
- Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug targetProceedings of the National Academy of Sciences of the United States of America, 1999
- Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated β-catenin–LEF-1 transcription complex in mouse colonic epithelial cells contrasting in ApcCarcinogenesis, 1999
- Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2Cell, 1996
- Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.Gut, 1994